Dear Colleagues,
The ABS issued a
press release
this morning supporting the continued utilization of HDR GYN Brachytherapy in the curative treatment of non- operable, locally advanced cervical cancer.
This is the third, in what we intend, will be an on-going public awareness communication campaign, to bring awareness to the media and general population, on the undeniable benefits of brachytherapy in appropriately selected patient across many disease sites.
We fully anticipate a positive impact from both efforts developed to drive increased awareness and utilization.
As I previously stated in the June 2018 BrachyBlast: Simply put, in the year to come we will take the gloves off, fight for what is right and unapologetically advocate for all things brachytherapy.
I look forward to your feedback.
Thank you & Best Regards,
Peter F. Orio, III DO, MS
President, ABS